Product Program year 2025 Source: CMS Open Payments

Novalung System

Device Heart and Lung Therapies

PDI 04057224902043

Open in the dashboard

General payments

$33,080

156 payments

Research payments

$0

0 payments

Through program year 2025, $33,080 in general payments and $0 in research payments were reported against Novalung System (Heart and Lung Therapies).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $727 10
2024 General $2,038 15
2023 General $4,425 48
2022 General $24,468 55
2021 General $1,423 28

Breakdown

Who paid General payments · program years 2021–2025
  1. Fresenius USA Marketing, Inc. $25,537 85 payments
  2. NxStage Medical, Inc. $7,543 71 payments
Top recipients General payments · program year 2025
  1. Jonathan Besas Pulmonary Disease · Fort Worth, TX $100 14% · 1 payment
  2. Erik Osborn Critical Care Medicine · Fredericksburg, VA $83 11% · 1 payment
  3. Bindu Akkanti Critical Care Medicine · Houston, TX $83 11% · 1 payment
  4. Rayan Ihle Pulmonary Disease · Charleston, WV $83 11% · 1 payment
  5. Nicholas Villalobos Critical Care Medicine · Houston, TX $83 11% · 1 payment

The top 5 of 10 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Critical Care Medicine Internal Medicine $427 59% · 6 practitioners
  2. Pulmonary Disease Internal Medicine $184 25% · 2 practitioners
  3. Nurse Practitioner $69 9% · 1 practitioner
  4. Nephrology Internal Medicine $48 7% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. Texas $560 77% · 8 recipients
  2. Virginia $83 11% · 1 recipient
  3. West Virginia $83 11% · 1 recipient

Each share is of general payments naming this product in 2025 where a state was reported.

156 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record